Related Experiment Video

Updated: May 15, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.2K

[New guidelines for atrial fibrillation]

Mashroor Khan1, Anna Björkenheim2, Emma Svennberg3

  • 1doktorand, leg -läkare, hjärtkliniken, ---Danderyds sjukhus, Stockholm.

Lakartidningen
|April 9, 2025
PubMed

Insights

The 2024 European Society of Cardiology guidelines introduce the AF-CARE framework for atrial fibrillation management. This holistic approach prioritizes comorbidities, stroke prevention, symptom reduction, and individualized reassessment for better patient outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine

Context:

  • Atrial fibrillation (AF) is a prevalent chronic cardiovascular condition requiring comprehensive management strategies.
  • The European Society of Cardiology (ESC) has released updated 2024 guidelines for AF treatment.
  • Current guidelines advocate for a patient-centered, holistic approach to managing AF complexities.

Purpose:

  • To outline the new 2024 ESC guidelines for atrial fibrillation management.
  • To introduce and explain the AF-CARE framework for a structured approach to AF care.
  • To emphasize a shift towards comprehensive, individualized AF management.

Summary:

  • The AF-CARE framework is introduced, comprising four key pillars: Comorbidities, Avoid stroke, Reduce symptoms, and Evaluation.
  • Comorbidities and risk factors are addressed for all AF patients, regardless of symptoms or stroke risk.
  • Strategies for stroke/thromboembolism avoidance, rate/rhythm control for symptom reduction, and dynamic, individualized reassessment are detailed.
  • The guidelines promote a proactive and adaptive management strategy for atrial fibrillation.

Impact:

  • The AF-CARE framework provides a structured, evidence-based approach to optimize atrial fibrillation patient care.
  • Implementation of these guidelines can lead to improved prognoses and reduced morbidity in AF patients.
  • These guidelines emphasize the importance of addressing the multifaceted nature of atrial fibrillation through personalized medicine.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.3K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.6K

Related Concept Videos

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
729
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
515
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
714
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
846